| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors K Takahashi, S Yamanaka cell 126 (4), 663-676, 2006 | 33723 | 2006 |
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors K Takahashi, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda, ... cell 131 (5), 861-872, 2007 | 25448 | 2007 |
| Generation of germline-competent induced pluripotent stem cells K Okita, T Ichisaka, S Yamanaka nature 448 (7151), 313-317, 2007 | 5772 | 2007 |
| The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells K Mitsui, Y Tokuzawa, H Itoh, K Segawa, M Murakami, K Takahashi, ... Cell 113 (5), 631-642, 2003 | 4219 | 2003 |
| Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts M Nakagawa, M Koyanagi, K Tanabe, K Takahashi, T Ichisaka, T Aoi, ... Nature biotechnology 26 (1), 101-106, 2008 | 3862 | 2008 |
| Generation of mouse induced pluripotent stem cells without viral vectors K Okita, M Nakagawa, H Hyenjong, T Ichisaka, S Yamanaka Science 322 (5903), 949-953, 2008 | 2744 | 2008 |
| A more efficient method to generate integration-free human iPS cells K Okita, Y Matsumura, Y Sato, A Okada, A Morizane, S Okamoto, H Hong, ... Nature methods 8 (5), 409-412, 2011 | 2262 | 2011 |
| Suppression of induced pluripotent stem cell generation by the p53–p21 pathway H Hong, K Takahashi, T Ichisaka, T Aoi, O Kanagawa, M Nakagawa, ... Nature 460 (7259), 1132-1135, 2009 | 1605 | 2009 |
| Induced pluripotent stem cell technology: a decade of progress Y Shi, H Inoue, JC Wu, S Yamanaka Nature reviews Drug discovery 16 (2), 115-130, 2017 | 1559 | 2017 |
| Generation of pluripotent stem cells from adult mouse liver and stomach cells T Aoi, K Yae, M Nakagawa, T Ichisaka, K Okita, K Takahashi, T Chiba, ... Science 321 (5889), 699-702, 2008 | 1534 | 2008 |
| Autologous induced stem-cell–derived retinal cells for macular degeneration M Mandai, A Watanabe, Y Kurimoto, Y Hirami, C Morinaga, T Daimon, ... New England Journal of Medicine 376 (11), 1038-1046, 2017 | 1479 | 2017 |
| Induction of pluripotent stem cells from fibroblast cultures K Takahashi, K Okita, M Nakagawa, S Yamanaka Nature protocols 2 (12), 3081-3089, 2007 | 1365 | 2007 |
| Nanog is the gateway to the pluripotent ground state J Silva, J Nichols, TW Theunissen, G Guo, AL van Oosten, O Barrandon, ... Cell 138 (4), 722-737, 2009 | 1278 | 2009 |
| Variation in the safety of induced pluripotent stem cell lines K Miura, Y Okada, T Aoi, A Okada, K Takahashi, K Okita, M Nakagawa, ... Nature biotechnology 27 (8), 743-745, 2009 | 1120 | 2009 |
| Strategies and new developments in the generation of patient-specific pluripotent stem cells S Yamanaka Cell stem cell 1 (1), 39-49, 2007 | 1101 | 2007 |
| Induced pluripotent stem cells: past, present, and future S Yamanaka Cell stem cell 10 (6), 678-684, 2012 | 1095 | 2012 |
| Hypoxia enhances the generation of induced pluripotent stem cells Y Yoshida, K Takahashi, K Okita, T Ichisaka, S Yamanaka Cell stem cell 5 (3), 237-241, 2009 | 1043 | 2009 |
| Nuclear reprogramming to a pluripotent state by three approaches S Yamanaka, HM Blau Nature 465 (7299), 704-712, 2010 | 1003 | 2010 |
| A fresh look at iPS cells S Yamanaka cell 137 (1), 13-17, 2009 | 961 | 2009 |
| Pluripotent stem cell-based cell therapy—promise and challenges S Yamanaka Cell stem cell 27 (4), 523-531, 2020 | 958 | 2020 |
Hideyuki OkanoKeio UniversityE-mail confirmado em keio.jp